Quick Answer
RetinalGenix Technologies Inc. reported R&D Expense of $373.3 thousand for fiscal year 2024.
RetinalGenix Technologies Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2024 | $373.3K | -28.8% |
| 2023 | $524.2K | -22.9% |
| 2021 | $680.3K | +57.6% |
| 2020 | $431.6K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $20.5K | -80.1% | +41.7% |
| June 30, 2025 | $14.4K | -82.6% | +9.2% |
| March 31, 2025 | $13.2K | -84.1% | -87.2% |
| September 30, 2024 | $103.0K | — | +24.2% |
| June 30, 2024 | $82.9K | -45.6% | -0.2% |
| March 31, 2024 | $83.1K | — | -45.5% |
| June 30, 2023 | $152.6K | +12.7% | +12.7% |
| June 30, 2022 | $135.4K | -15.3% | -32.6% |
- RetinalGenix Technologies Inc. showed a decrease of -28.8% in R&D Expense compared to the prior fiscal year.
- Over the 2020–2024 period, RetinalGenix Technologies Inc.’s r&d expense has declined by 13.5% (from $431.6 thousand to $373.3 thousand).
- The most recent figure is from RetinalGenix Technologies Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: